Private Equity

Barings BDC maintained its dividend, but a dip in income and net asset value reveals underlying challenges in a volatile market for private credit.

Facing financial pressures, the biotech divests a key cancer program, repays debt, and now explores all options to maximize value for its remaining pipeline.

As insurers invest billions in opaque private loans, state and federal officials are coordinating to manage hidden risks for policyholders and the financial system.

Rogers Corporation adds two powerhouse CEOs to its board, signaling a strategic push to dominate high-growth markets like EVs and advanced industrial tech.

Elysium Investments plans a 200-bed residence in downtown Toronto, but can a single project make a dent in the city's severe student housing shortage?

GreenPointe Holdings has started construction on a 900-acre community, promising a nature-focused lifestyle amid questions about Tallahassee's rapid growth.

As it nears $10B in assets, investment firm Disruptive hires a top tech advisor, signaling a new phase of strategic growth for its unique investment model.

With key clinical data on the horizon for its cancer and ALS drugs, LeonaBio adds deep financial, operational, and strategic expertise to its leadership.

With key leadership hires, Hudson Valley Property Group is scaling up to meet soaring investor demand for impact-driven affordable housing preservation.

The firm's oversubscribed Collateralized Fund Obligation highlights a major shift in how institutional investors access private markets.

Warner Bros. Discovery unveils a massive 30th-anniversary campaign for Space Jam, blending nostalgia with a modern, multi-platform business strategy.

The healthcare investment bank's new hire signals a major push to dominate the lucrative, complex, and high-stakes world of private equity dealmaking.

A massive $250M investment could replace a 40-pill daily burden with a single tablet for patients with pancreatic insufficiency, disrupting a market in crisis.

From the makers of the 'World's Best Tequila,' a new Reposado redefines aging with a unique blend of Sauternes, Sherry, and Bourbon casks.

A former refugee's art raises $70,000 at auction, embodying a shared philosophy of turning adversity into possibility with Jane Seymour's Foundation.

The acquisition merges point-of-care marketing with digital HCP engagement, creating a powerhouse to reshape how pharma brands connect with doctors and patients.

A historic UN petition reframes the Xinjiang crisis, accusing China of colonialism and demanding decolonization for East Turkistan after years of failed diplomacy.

After 30 years, Straine consolidates its consulting, analytics, and management arms, a strategic move to clarify its integrated model in a competitive market.

With backing from an NBA owner, snacking dough brand Doich hires a new COO to lead its push into major grocery chains and the 'better-for-you' market.

T. Rowe Price's private credit fund posts a 10.6% distribution rate, but a drop in net asset value and negative earnings raise deeper questions.